Ironwood Pharmaceuticals, Inc. (IRWD)
Makes medicines treating digestive disorders and chronic pain conditions.
$3.87-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+401.9%
The outlook
Ironwood Pharmaceuticals trades at $3.87, positioned solidly above its 50- and 200-day averages and about midway through its 52-week range. Analyst consensus leans Buy with an average price target implying roughly 64% upside from current levels, though coverage is modest at four analysts. The stock carries a low trailing P/E of 6.2 and scores a bullish lean overall.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range62% of the way from its 52-week low to high
Price targetAvg target +64% vs current price
Analyst price target
~12-month · 4 analysts$6.35average target+64.3% vs now
Now $3.87
Low $3.70High $11.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$636.2M
52-wk high
$5.78
52-wk low
$0.72
50-day avg
$3.83
200-day avg
$3.61
Trailing P/E
6.2